BCR/ABL Regulates Expression of the Cyclin-dependent Kinase Inhibitor p27Kip1 through the Phosphatidylinositol 3-Kinase/AKT Pathway

This publication has 54 references indexed in Scilit:

• Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic Factors
  The Journal of cell biology, 2000
• Mutator phenotype of BCR – ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase β
  Oncogene, 1999
• Expression of G1-Phase Cell Cycle Genes during Hematopoietic Lineage
  Biochemical and Biophysical Research Communications, 1997
• Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
  The Journal of Experimental Medicine, 1996
• Cyclin D1 provides a link between development and oncogenesis in the retina and breast
  Cell, 1995
• Differential Complementation of Bcr-Abl Point Mutants with c-Myc
  Science, 1994
• Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
  Nature Genetics, 1993
• Dominant negative MYC blocks transformation by ABL oncogenes
  Cell, 1992
• Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
  Science, 1990
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
  Nature, 1973